Soros Fund Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Soros Fund Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,200	Closed	-$224K	–	305
2016 Q1	$224K	Buy	+4,200	New	+$310K	﹤0.01%	212

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Soros Fund Management's ANAC Position: Q2 2016 in Review

Soros Fund Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,200 shares — an estimated $224K sold.

Soros Fund Management first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $224K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Soros Fund Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Soros Fund Management sold 4,200 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $224K.
Soros Fund Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Soros Fund Management's ANACOR PHARMACEUTICALS INC COM position peaked at $224K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.